A detailed history of Grove Bank & Trust transactions in Organon & Co. stock. As of the latest transaction made, Grove Bank & Trust holds 494 shares of OGN stock, worth $7,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares
494
Previous 494 -0.0%
Holding current value
$7,276
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$13.78 - $18.8 $68 - $94
-5 Reduced 1.0%
494 $9,000
Q4 2023

Jan 30, 2024

SELL
$10.95 - $17.32 $2,649 - $4,191
-242 Reduced 32.66%
499 $7,000
Q3 2023

Oct 30, 2023

SELL
$16.59 - $23.77 $2,057 - $2,947
-124 Reduced 14.34%
741 $12,000
Q2 2023

Jul 27, 2023

SELL
$19.27 - $24.63 $3,776 - $4,827
-196 Reduced 18.47%
865 $18,000
Q1 2023

May 10, 2023

SELL
$21.42 - $32.08 $985 - $1,475
-46 Reduced 4.16%
1,061 $24,000
Q4 2022

Feb 03, 2023

BUY
$23.31 - $28.61 $25,804 - $31,671
1,107 New
1,107 $31,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.